Article
Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates.
Journal of translational medicine - 9 Jul 2020
Chitranshi Nitin, Gupta Vivek K, Rajput Rashi, Godinez Angela, Pushpitha Kanishka, Shen Ting, Mirzaei Mehdi, You Yuyi, Basavarajappa Devaraj, Gupta Veer, Graham Stuart L
Abstract excerpt
BACKGROUND: Severe acute respiratory syndrome (SARS) has been initiating pandemics since the beginning of the century. In December 2019, the world was hit again by a devastating SARS episode that has so far infected almost four million individuals worldwide, with over 200,000 fatalities having already occurred by mid-April 2020, and the infection rate continues to grow exponentially. SARS coronavirus 2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
